Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

In July BB Biotech’s share price increased by 10.3% in CHF, and the Net Asset Value (NAV) increased by 8.7% in USD, while the Nasdaq Biotechnology Index (NBI) was up by 5.5% in USD.<br />
<br />
We experienced more positive sentiment in the biotech sector in July and noted several positive updates from portfolio companies, including Argenx, one of BB Biotech’s core holdings, which significantly exceeded its Q2 expectations.

BB Biotech Update July 2025

In July BB Biotech’s share price increased by 10.3% in CHF, and the Net Asset Value (NAV) increased by 8.7% in USD, while the Nasdaq Biotechnology Index (NBI) was up by 5.5% in USD.

We experienced more positive sentiment in the biotech sector in July and noted several positive updates from portfolio companies, including Argenx, one of BB Biotech’s core holdings, which significantly exceeded its Q2 expectations.
19.08.2025 - BB Biotech